title: [2013 annual meeting of the International Society for the Study of Women's Sexual Health (ISSWSH), 28 February-3 March 2013, New Orleans, Louisiana, USA. State of pharmacologial research in Women's Sexual Medicine: From testosterone to bremelatonide].
authors: CETPARP, 3 rue Carolus, Lille, France.
authors: J
authors: J
authors: Buvat
mesh_terms: D001562:Benzimidazoles / Q000627:therapeutic use; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D005260:Female; D006801:Humans; D010456:Peptides, Cyclic / Q000627:therapeutic use; D044101:Receptors, Melanocortin / Q000819:agonists; D060728:Reproductive Health; D058825:Serotonin 5-HT1 Receptor Agonists; D058830:Serotonin 5-HT2 Receptor Antagonists; D020018:Sexual Dysfunctions, Psychological / Q000139:chemically induced / Q000188:drug therapy; D013739:Testosterone / Q000627:therapeutic use; D016387:Women's Health; D000521:alpha-MSH / Q000627:therapeutic use
chemical_list: D001562:Benzimidazoles; D003278:Contraceptives, Oral, Hormonal; D010456:Peptides, Cyclic; D044101:Receptors, Melanocortin; D058825:Serotonin 5-HT1 Receptor Agonists; D058830:Serotonin 5-HT2 Receptor Antagonists; C098107:flibanserin; D013739:Testosterone; D000521:alpha-MSH; C476721:bremelanotide